165 filings
Page 2 of 9
25-NSE
xyzprn
21 Dec 22
Exchange delisting
6:08am
8-K
hh7uz
2 Dec 22
Departure of Directors or Certain Officers
4:19pm
8-K
96kfak8
23 Nov 22
Departure of Directors or Certain Officers
4:08pm
NT 10-Q
0twgy 89o9m
15 Nov 22
Notice of late quarterly filing
4:21pm
8-K
bbbpdr 71is25eczmvev
8 Nov 22
Entry into a Material Definitive Agreement
5:21pm
8-K
64ihbc9
31 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:21pm
8-K
540bij
24 Oct 22
Bankruptcy or Receivership
8:02am
8-K
iz3ni 5rqslirwf0tp
7 Oct 22
Entry into a Material Definitive Agreement
5:20pm
8-K
y02kbmwcvy6zpy2id5wt
27 Sep 22
Other Events
5:00pm
8-K
mafcgosil 57
12 Aug 22
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:32am
8-K
m69t08esjpiky
8 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:14pm
8-K
n2k 4sfj4s6
5 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
8-K
zoctrmg4ff 2gvj
20 May 22
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
khmiy 1m5
16 May 22
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
12:00am
8-K
ick3dfol742hant 6c30
4 Apr 22
PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
4:35pm
8-K
0kwg9gb9r aeke
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm